Makers Laboratories Ltd

Makers Labs. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Makers Laboratories Ltd

₹ 158 2.13%
18 Mar 4:01 p.m.
makerslabs.com BSE: 506919
About

Incorporated in 1984, Makers Laboratories
Ltd is in the business of manufacturing and marketing of pharmaceuticals

Key Points

Business Overview:[1][2][3]
The company markets 200+ generic formulations in India across major therapeutic segments like anti-malarial, antibiotics, anti-inflammatory, analgesics, and anti-diabetics, catering to dispensing doctors, nursing homes, and hospitals. It also undertakes job work for injectables (anti-malarial) for IPCA and procures products on a P2P basis from manufacturers in Himachal Pradesh and Uttarakhand's excise-free zones.

Website BSE
  • Market Cap ₹ 93.2 Cr.
  • Current Price ₹ 158
  • High / Low ₹ 174 / 109
  • Stock P/E
  • Book Value ₹ 94.0
  • Dividend Yield 0.00 %
  • ROCE -6.79 %
  • ROE -9.63 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -3.53% over past five years.
  • Company has a low return on equity of -11.4% over last 3 years.
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
10.63 10.84 11.54 14.92 11.17 11.45 12.29 11.50 9.45 9.70 13.73 12.64 12.70
12.48 11.02 13.32 15.63 12.28 11.59 12.56 11.66 10.01 10.92 13.27 12.72 11.98
Operating Profit -1.85 -0.18 -1.78 -0.71 -1.11 -0.14 -0.27 -0.16 -0.56 -1.22 0.46 -0.08 0.72
OPM % -17.40% -1.66% -15.42% -4.76% -9.94% -1.22% -2.20% -1.39% -5.93% -12.58% 3.35% -0.63% 5.67%
0.14 0.18 0.19 0.69 0.12 0.15 0.14 10.19 0.57 0.03 0.04 0.53 -0.00
Interest 0.40 0.28 0.35 0.41 0.42 0.46 0.39 0.33 0.13 0.09 0.10 0.15 0.15
Depreciation 0.66 0.66 0.67 0.68 0.68 0.68 0.71 0.71 0.73 0.69 0.70 0.71 0.71
Profit before tax -2.77 -0.94 -2.61 -1.11 -2.09 -1.13 -1.23 8.99 -0.85 -1.97 -0.30 -0.41 -0.14
Tax % -7.58% -12.77% -5.75% -10.81% -7.18% 37.17% -1.63% 10.57% -9.41% -28.93% -10.00% -24.39% 21.43%
-2.57 -0.80 -2.46 -0.99 -1.95 -1.56 -1.22 8.03 -0.77 -1.40 -0.27 -0.31 -0.17
EPS in Rs -4.36 -1.36 -4.17 -1.68 -3.30 -2.64 -2.07 13.61 -1.30 -2.37 -0.46 -0.53 -0.29
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
68.37 64.91 61.41 58.13 55.95 46.60 51.31 44.34 52.34 42.46 48.85 42.87 48.77
65.93 60.53 56.71 52.69 51.28 44.38 48.55 41.03 49.24 46.60 52.60 45.07 48.89
Operating Profit 2.44 4.38 4.70 5.44 4.67 2.22 2.76 3.31 3.10 -4.14 -3.75 -2.20 -0.12
OPM % 3.57% 6.75% 7.65% 9.36% 8.35% 4.76% 5.38% 7.47% 5.92% -9.75% -7.68% -5.13% -0.25%
0.21 0.94 0.41 1.24 1.50 2.56 0.18 0.41 0.80 1.14 1.14 10.92 0.60
Interest 0.49 0.39 0.36 0.27 0.36 0.26 0.70 1.60 1.68 1.38 1.63 0.94 0.49
Depreciation 0.97 1.53 1.25 1.08 1.57 1.50 1.99 4.20 1.91 2.40 2.71 2.85 2.81
Profit before tax 1.19 3.40 3.50 5.33 4.24 3.02 0.25 -2.08 0.31 -6.78 -6.95 4.93 -2.82
Tax % 50.42% 30.88% 34.29% 30.77% 27.83% 18.87% 148.00% -22.12% 45.16% -6.05% -0.00% 5.88%
0.60 2.35 2.31 3.70 3.06 2.45 -0.12 -1.62 0.17 -6.36 -6.95 4.64 -2.15
EPS in Rs 1.02 3.98 3.92 6.27 5.19 4.15 -0.20 -2.75 0.29 -10.78 -11.78 7.86 -3.65
Dividend Payout % -0.00% 20.94% 21.30% 13.30% 16.08% 20.08% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00%
Compounded Sales Growth
10 Years: -4%
5 Years: -4%
3 Years: -6%
TTM: 9%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -148%
Stock Price CAGR
10 Years: 11%
5 Years: -9%
3 Years: 14%
1 Year: 19%
Return on Equity
10 Years: -2%
5 Years: -8%
3 Years: -11%
Last Year: -10%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 4.92 4.92 4.92 4.92 4.92 4.92 4.92 4.92 4.92 5.90 5.90 5.90 5.90
Reserves 17.99 19.71 21.42 29.15 31.90 36.78 39.70 44.70 45.38 52.38 45.55 50.18 49.54
2.12 0.80 0.18 1.43 1.29 6.38 13.05 15.99 19.40 11.20 15.37 1.76 5.18
15.99 13.67 13.68 14.70 15.18 11.94 16.20 13.51 15.78 15.30 19.33 13.55 14.14
Total Liabilities 41.02 39.10 40.20 50.20 53.29 60.02 73.87 79.12 85.48 84.78 86.15 71.39 74.76
11.94 11.47 10.39 17.30 16.62 18.10 32.89 30.59 29.94 40.45 39.88 29.38 28.12
CWIP 1.92 2.71 4.23 0.15 0.11 6.42 0.69 0.12 8.94 0.04 -0.00 0.04 0.10
Investments 2.50 2.35 2.35 7.12 9.18 11.16 15.04 23.66 22.55 22.52 22.56 22.59 22.57
24.66 22.57 23.23 25.63 27.38 24.34 25.25 24.75 24.05 21.77 23.71 19.38 23.97
Total Assets 41.02 39.10 40.20 50.20 53.29 60.02 73.87 79.12 85.48 84.78 86.15 71.39 74.76

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1.30 1.32 3.52 5.53 0.21 5.39 4.23 0.67 6.80 -1.42 -3.06 -1.59
-1.12 -1.00 -1.49 -2.96 -2.06 -8.31 -8.43 -2.65 -8.78 -3.55 -2.04 16.14
-0.45 -0.38 -0.91 0.39 -1.09 3.92 2.91 1.37 1.77 4.94 5.12 -14.56
Net Cash Flow -0.27 -0.06 1.12 2.96 -2.95 1.00 -1.29 -0.61 -0.21 -0.04 0.02 -0.01

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 66.89 66.58 85.65 75.73 73.20 39.32 53.71 59.19 37.31 64.73 49.09 44.78
Inventory Days 82.37 83.67 60.14 84.04 135.66 147.65 132.22 176.97 159.36 109.67 135.03 122.14
Days Payable 86.93 68.30 73.93 75.31 67.88 49.81 90.79 98.48 52.16 61.39 101.09 98.05
Cash Conversion Cycle 62.33 81.96 71.87 84.46 140.97 137.16 95.14 137.68 144.51 113.01 83.03 68.87
Working Capital Days 54.61 67.03 70.85 35.79 70.91 72.45 24.47 14.74 -59.28 -15.73 -36.99 21.71
ROCE % 7.81% 13.08% 15.63% 15.54% 13.15% 7.63% 1.80% -1.05% 3.02% -7.77% -7.84% -6.79%

Insights

In beta
Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
R&D Expenditure
INR Lakhs

Log in to view insights

Please log in to see hidden values.

Login
Total Employees
Number
Number of Generic Formulations (SKUs) Marketed
Number
Installed Capacity - Liquid Injectables (Ampoules)
Lakh units per annum
Installed Capacity - Liquid Injectables (Vials)
Lakh units per annum
Number of Major Depots
Number
Marketing Field Force Strength
Number

Shareholding Pattern

Numbers in percentages

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.39% 0.39% 0.39% 0.39% 0.39%
38.72% 38.73% 38.73% 38.74% 38.73% 38.74% 38.73% 38.33% 38.34% 38.35% 38.35% 38.35%
No. of Shareholders 4,4834,4024,2834,1794,1764,0904,0084,0314,1354,0734,0263,926

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Right Issue

Credit ratings